The board of directors at Exalys Therapeutics has a history of experience in the medical field and in various aspects of business. The board members have worked as chief medical officers, head of research and development, managing partners, and executive directors at companies such as Travecta Therapeutics, Adynxx, Inc., Shionogi Inc., and Morgan Stanley. They also have a wide range of educational backgrounds, including degrees in pain management, regional anesthesia, anesthesiology, and critical care medicine from the Johns Hopkins University School of Medicine.
View all